This article is more than 5 years old. Information may no longer be current.

Stay Current With Our Peer-Tested Content

Issue: March 2016

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Welcome to the launch of Healio Rheumatology, a print publication based on the most important news as measured by the online preferences of your colleagues.

In this issue, you will find the most-read content from readers of Healio.com/Rheum, our online news site for rheumatology. We call this unique approach to issue content selection “Peer-Tested Content” and we believe the approach will provide you the best and most valuable content in rheumatology.

Each issue features a Cover Story in which we look at a topic in-depth. For this first issue, Eric Matteson, MD; S. Louis Bridges Jr., MD; Jeffrey R. Curtis, MD, MS, MPH; Allan Gibofsky, MD, JD, FACP, FCLM; and James R. O’Dell, MD, shared their thoughts on the new guideline from the American College of Rheumatology on the treatment of rheumatoid arthritis. In the Editorial, Leonard H. Calabrese, DO, the Chief Medical Editor of Healio Rheumatology, provides additional perspective to the current guideline.

In Trend Watch, we feature breaking news of industry that affects patients and practice. Guidelines highlights the most recent changes to published recommendations in rheumatology. Drug Pipeline covers drug discovery and development as well as news of recent FDA approvals. In the Journals features our executive summaries of rheumatology’s most recently published peer-reviewed journal articles. In addition, we feature Meeting News Coverage to bring readers the most important highlights from rheumatology meetings and congresses. We also introduce an educational activity from our Education Lab, an area of Healio.com where physicians participate in continuing medical education.

We thank Dr. Calabrese and the Peer Perspective Board for helping us bring this publication to rheumatology. We hope Healio.com/Rheum becomes your daily destination for breaking news. Based on your online preferences, Healio Rheumatology aims to help you stay current on the research and clinical experience of your peers. Thanks for reading.

The Editors
Healio Rheumatology
rheumatology@healio.com